Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Aerpio Pharmaceuticals stock | $2.06

Own Aerpio Pharmaceuticals stock in just a few minutes.

Fact checked

Aerpio Pharmaceuticals, Inc is a biotechnology business based in the US. Aerpio Pharmaceuticals shares (ARPO) are listed on the NASDAQ and all prices are listed in US Dollars. Aerpio Pharmaceuticals employs 12 staff and has a trailing 12-month revenue of around USD$15 million.

How to buy shares in Aerpio Pharmaceuticals

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Aerpio Pharmaceuticals. Find the stock by name or ticker symbol: ARPO. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Aerpio Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$2.06, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Aerpio Pharmaceuticals, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Aerpio Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Aerpio Pharmaceuticals share price

Use our graph to track the performance of ARPO stocks over time.

Aerpio Pharmaceuticals shares at a glance

Information last updated 2020-12-26.
Latest market closeUSD$2.06
52-week rangeUSD$0.42 - USD$2.29
50-day moving average USD$1.5268
200-day moving average USD$1.4071
Wall St. target priceUSD$1.75
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.275

Buy Aerpio Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Aerpio Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aerpio Pharmaceuticals price performance over time

Historical closes compared with the close of $2.06 from 2020-12-09

1 week (2021-01-07) 82.30%
1 month (2020-12-17) 100.00%
3 months (2020-10-15) 51.47%
6 months (2020-07-15) 53.73%
1 year (2020-01-15) 233.77%
2 years (2019-01-15) -28.72%
3 years (2018-01-13) N/A
5 years (2016-01-13) N/A

Aerpio Pharmaceuticals financials

Revenue TTM USD$15 million
Gross profit TTM USD$0
Return on assets TTM -5.75%
Return on equity TTM -9.08%
Profit margin -26.96%
Book value $1.004
Market capitalisation USD$49.5 million

TTM: trailing 12 months

Shorting Aerpio Pharmaceuticals shares

There are currently 1.8 million Aerpio Pharmaceuticals shares held short by investors – that's known as Aerpio Pharmaceuticals's "short interest". This figure is 6.2% up from 1.7 million last month.

There are a few different ways that this level of interest in shorting Aerpio Pharmaceuticals shares can be evaluated.

Aerpio Pharmaceuticals's "short interest ratio" (SIR)

Aerpio Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Aerpio Pharmaceuticals shares currently shorted divided by the average quantity of Aerpio Pharmaceuticals shares traded daily (recently around 8.4 million). Aerpio Pharmaceuticals's SIR currently stands at 0.21. In other words for every 100,000 Aerpio Pharmaceuticals shares traded daily on the market, roughly 210 shares are currently held short.

However Aerpio Pharmaceuticals's short interest can also be evaluated against the total number of Aerpio Pharmaceuticals shares, or, against the total number of tradable Aerpio Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aerpio Pharmaceuticals's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Aerpio Pharmaceuticals shares in existence, roughly 10 shares are currently held short) or 0.0175% of the tradable shares (for every 100,000 tradable Aerpio Pharmaceuticals shares, roughly 18 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Aerpio Pharmaceuticals.

Find out more about how you can short Aerpio Pharmaceuticals stock.

Aerpio Pharmaceuticals share dividends

We're not expecting Aerpio Pharmaceuticals to pay a dividend over the next 12 months.

Aerpio Pharmaceuticals share price volatility

Over the last 12 months, Aerpio Pharmaceuticals's shares have ranged in value from as little as $0.42 up to $2.29. A popular way to gauge a stock's volatility is its "beta".

ARPO.US volatility(beta: 2.05)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aerpio Pharmaceuticals's is 2.0482. This would suggest that Aerpio Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Aerpio Pharmaceuticals overview

Aerpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing compounds for the treatment of ocular diseases and diabetic complications. The company's lead product candidate is razuprotafib, a small molecule activator of the Tie2 pathway, which completed the Phase IIb clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; GB004, a selective stabilizer of hypoxia-inducible factor-1 alpha, which is in a Phase 1b clinical trial for the treatment of inflammatory bowel disease; and bispecific antibody for the treatment for wet age-related macular degeneration and DME through intravitreal injection. Aerpio Pharmaceuticals, Inc. has a collaboration with Quantum Leap Healthcare Collaborative for the evaluation of razuprotafib in the treatment of acute respiratory distress syndrome in adult patients with moderate to severe COVID-19. The company is headquartered in Cincinnati, Ohio.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site